Changes in the ER, PgR, HER2, p53 and Ki-67 biological markers between primary and recurrent breast cancer: discordance rates and prognosis

Prognostic significance of Ki67 index after neoadjuvant chemotherapy in breast cancer

(2010) T. Tanei et al.   EJSO

Comparative study of the immunohistochemical detection of hormone receptor status and HER-2 expression in primary and paired recurrent/metastatic lesions of patients with breast cancer

(2010) Ebru Sari et al.   MEDICAL ONCOLOGY

Does Analysis of Biomarkers in Tumor Cells in Lymph Node Metastases Give Additional Prognostic Information in Primary Breast Cancer?

(2010) Anna-Karin Falck et al.   WORLD JOURNAL OF SURGERY

Prognostic impact of discordance between triple-receptor measurements in primary and recurrent breast cancer

(2009) C. Liedtke et al.   ANNALS OF ONCOLOGY

Does confirmatory tumor biopsy alter the management of breast cancer patients with distant metastases?

(2009) C. Simmons et al.   ANNALS OF ONCOLOGY

Thresholds for therapies: highlights of the St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2009

(2009) A. Goldhirsch et al.   ANNALS OF ONCOLOGY

Clinical significance of Ki-67 in neoadjuvant chemotherapy for primary breast cancer as a predictor for chemosensitivity and for prognosis

(2009) Reiki Nishimura et al.   Breast Cancer

Emerging Biomarkers and New Understanding of Traditional Markers in Personalized Therapy for Breast Cancer

(2008) M. Dowsett et al.   CLINICAL CANCER RESEARCH